Research papers of the week - Feburary 6, 2022

Monika Kasztura, Liliana Kiczak, Urszula Pasławska, Jacek Bania, Adrian Janiszewski, Alicja Tomaszek, Maciej Zacharski, Agnieszka Noszczyk-Nowak, Robert Pasławski, Aleksandra Tabiś, Piotr Kuropka, Piotr Dzięgiel, Piotr Ponikowski

International Journal of Molecular Sciences

Ministerial score = 140.0
Journal Impact Factor (2020) = 5.924(Q1)

Despite advances in the management of iron deficiency in heart failure (HF), the mechanisms underlying the effects of treatment remain to be established. Iron distribution and metabolism in HF pathogenesis need to be clarified. We used a porcine tachycardia-induced cardiomyopathy model to find out how HF development influences hepatic and myocardial iron storing, focusing on ferritin, the main iron storage protein. We found that cumulative liver congestion (due to the decrease of heart function) overwhelms its capacity to recycle iron from erythrocytes. As a consequence, iron is trapped in the liver as poorly mobilized hemosiderin. What is more, the ferritin-bound Fe3+ (reflecting bioavailable iron stores), and assembled ferritin (reflecting ability to store iron) are decreased in HF progression in the liver. We demonstrate that while HF pigs show iron deficiency indices, erythropoiesis is enhanced. Renin–angiotensin–aldosterone system activation and hepatic hepcidin suppression might indicate stress erythropoiesisinduced in HF. Furthermore, assembled ferritin increases but ferritin-bound Fe3+ is reduced in myocardium, indicating that a failing heart increases the iron storage reserve but iron deficiency leads to a drop in myocardial iron stores. Together, HF in pigs leads to down-regulated iron bioavailability and reduced hepatic iron storage making iron unavailable for systemic/cardiac needs.

DOI:10.3390/ijms23031026

READ THE PAPER UPWr Base